1. Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
   Yeo-Jung Kwon et al, 2021, Archives of Pharmacal Research CrossRef
2. The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro
   Sarah Schott et al, 2017, Oncotarget CrossRef
3. High co-expression of the SDF1/CXCR4 axis in hepatocarcinoma cells is regulated by AnnexinA7 in vitro and in vivo
   Jingwen Wang et al, 2018, Cell Communication and Signaling CrossRef
4. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
   Liping Qiu et al, 2022, BMC Cancer CrossRef
5. Chemokines network in bone metastasis: Vital regulators of seeding and soiling
   Gunjan Sharma et al, 2022, Seminars in Cancer Biology CrossRef
6. CYP1B1 as a therapeutic target in cardio-oncology
   Alexa N. Carrera et al, 2020, Clinical Science CrossRef
7. Design, synthesis and biological evaluation of highly potent and selective CYP1B1 inhibitors
   Haoyu Zhang et al, 2023, New Journal of Chemistry CrossRef
8. Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer
   Erica Yada et al, 2021, Biomedicines CrossRef
9. The CXCL12 Crossroads in Cancer Stem Cells and Their Niche
   Juan Carlos López-Gil et al, 2021, Cancers CrossRef
10. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme
    Rajni Sharma et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
11. Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
    Muttanagouda Giriyappagoudar et al, 2023, Biomedicines CrossRef
12. TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
    Ke Zhang et al, 2020, Cancer Cell International CrossRef
13. Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1
    Baddipadige Raju et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
14. In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4
    Isaline Renard et al, 2023, Nuclear Medicine and Biology CrossRef
15. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer
    Lili Wang et al, 2024, The Prostate CrossRef
16. Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
    Laxmi Manthalkar et al, 2022, Discover Oncology CrossRef
17. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo‐YAP signaling pathway
    Chun‐Hui Zheng et al, 2018, Cell Biology International CrossRef
18. From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
    Nourhan M. Abdelmaksoud et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
19. An Overview of Lung Cancer in Women and the Impact of Estrogen in Lung Carcinogenesis and Lung Cancer Treatment
    Vianey Rodriguez-Lara et al, 2021, Frontiers in Medicine CrossRef
20. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia
    Xueliang Gao et al, 2021, Journal of Clinical Investigation CrossRef
21. Investigation of CYP1B1*3 and CYP1B1*4 polymorphisms in a Turkish population
    Fatma Özlem Solmaz Kargın et al, 2022, HEALTH SCIENCES QUARTERLY CrossRef